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ABSTRACT
Beesetty, Pavani. M.S., Department of Pharmacology and Toxicology, Wright State
University, 2013. Role of bax, ibpA, ibpB and cspH genes in protecting CFT073
(Uropathogenic Escherichia coli) against salt and urea stress.
Uropathogenic Escherichia coli (UPEC) are the primary cause of 80 to 90% of
uncomplicated urinary tract infections. After entering the urinary tract, uropathogenic
E.coli has to tolerate high levels of salt and urea in urine to cause a successful infection.
The osmotic stress imposed by urea is different from that by NaCl, as urea can freely
move across the cell membrane and is a protein denaturant. Hence, microarray
experiments were performed to observe the differential expression of genes in CFT073
(UPEC) due to the presence of 0.3 M NaCl and 0.6 M urea in K medium individually.
Based on the results, Bax (a hypothetical protein), IbpAB (small heat shock chaperone
proteins) and CspH (speculated to be DNA/RNA chaperone protein) were chosen for the
current study in which their role in protecting CFT073 against salt or urea stress was
investigated. First bax, ibpAB and cspH gene sequences were shown to be well conserved
among commensal E.coli MG1655 and 3 different UPEC strains CFT073, UTI89 and
E.coli 536. Then GFP transcriptional fusion plasmids were constructed for bax, ibpAB
and cspH genes and promoter activity assays were performed in K medium. Results
showed that in CFT073, expression of bax was induced significantly in the presence of
0.2 M and 0.3 M NaCl, and expression of ibpAB and cspH genes were induced in the
presence of 0.3 M and 0.6 M urea in K medium, though the induction in cspH expression
needs further confirmation. It was also shown that RpoS sigma factor does not regulate
the expression of these genes during high levels of salt or urea in K medium. To study the
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importance of each gene in protecting CFT073 and BW25113 (K-12 strain) against salt
or urea stress, growth curve experiments were performed using bax, ibpAB and cspH
knockouts of each strain. Results showed that bax deletion reduced the salt tolerance of
BW25113 but had no effect on the salt tolerance of CFT073. Deletion of ibpAB operon
did not affect the urea tolerance of CFT073 and BW25113. However cspH null mutant of
BW25113 showed reduced growth rate in the presence of 0.9 M urea in M9 medium
compared to its wild type strain, and further experiments are needed to determine if cspH
knockout would produce a similar effect in CFT073. Based on the current study, it can
be concluded that even though the expression of bax and ibpAB genes are induced during
salt and urea stress respectively, these genes are dispensable for CFT073 to tolerate high
levels of salt or urea in K medium and M9 medium.
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INTRODUCTION
Urinary tract infection (UTI): Epidemiology
Infection of urinary tract with microbial pathogens leads to UTI. Urinary tract infections
are responsible for 8.27 million office visits, 1.7 million emergency room visits and
366,000 hospitalizations with an annual cost of $3.4 billion in the United States alone
during 2000, as shown by the following table (1).
Year 2000

Office visits

Emergency room visits

Hospitalizations Annual cost

Women

6.8 million

1.3 million

2,45,000

$2.4 billion

Men

1.4 million

0.4 million

1,21,000

$1 billion

About 40% to 50% of women are experiencing at least one episode of UTI during their
life time, with 1 in every 3 women having their first UTI by the age of 24 (2). Though
UTI are acute self-limiting infections, the rate of recurrence is usually high. In children,
UTI is an important cause of morbidity effecting 10% of childhood population (3).
Though the occurrence of UTI is very low in young males due to a longer urethra, and the
release of antibacterial substances and immunoglobulin gamma A (IgA) locally from the
prostate gland, the rate is usually high during their early childhood and later stages of life
(4, 5).
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Classification and Clinical Manifestations of UTI
UTI are mainly classified as Uncomplicated (infection in a healthy individual with a
normal genitourinary tract) and Complicated UTI (infection in catheterized, structurally
or functionally abnormal genitourinary tract or in immune compromised patients (4).
The 3 main clinical manifestations of UTI include cystitis (infection of bladder with
symptoms like dysuria, frequency and urgency of urination, and sometimes suprapubic
pain), acute pyelonephritis (infection of kidney with flank pain, fever, nausea, vomiting,
sweats and malaise as symptoms) and asymptomatic bacteriuria (patient consistently
shows significant quantity of bacteria in the urine but with no symptoms of infection) (2,
4, 6, 7).
Causative agents for UTI
About 80-90% of uncomplicated UTIs are caused by Escherichia coli, 10-15% by
Staphylococcus saprophyticus and 5% by other enterobacteriaceae like Klebsiella,
Proteus, enterobacter and enterococci. Only 20% of complicated UTI are caused by
E.coli, other causative agents being Candida Spp., Staphylococcus aureus, Klebsiella
spp., Enterobacter cloacae, Serratia marcescens, Proteus mirabilis, Pseudomonas
aeruginosa, Enterococcus faecalis, Group B streptococci, etc (5, 8). Even a less virulent
strain can cause successful infection during a complicated UTI. Thus the range of
organisms which can cause complicated UTIs are broader (7-9).
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Uropathogenesis of E.coli
Escherichia coli are the common inhabitants of the human and animal gut. It maintains a
symbiotic relationship with its host and helps in intestinal tract functional maturation,
microbial flora stabilization and immune response regulation in the host intestine (10).
However some strains of E. coli become pathogenic by acquiring virulent factors through
horizontal transfer of plasmids, pathogenicity islands, transposons and bacteriophages
(11). These pathogenic strains are classified as enteric/diarrheagenic E. coli and
extraintestinal E. coli (ExPEC). Uropathogenic E. coli (UPEC) are a highly
heterogeneous group of E. coli which belong to ExPEC. They reside in the human
intestine without producing any disease but can disseminate and colonize the host urinary
tract and cause urinary tract infection (11).
UPEC strains are expected to be transmitted from one person to another by sex, food,
water or through the hands of hospital personnel (7). Once UPEC enters the intestine it
forms a reservoir in the gut which can colonize the periurethral area or vaginal introitus,
ascend to the bladder through the urethra and cause bladder infection (12). The exact
mechanism of bacterial migration from introitus to bladder is still unknown (13).
However sexual intercourse is considered to be an important factor that facilitates this
migration (4). Some strains can further ascend to the kidneys, with the help of flagella,
producing pyelonephritis (14, 15). The pathogenesis of pyelonephritis is relatively less
studied compared to cystitis. The above described path is considered to be the major
route for UTI and is called ascending UTI. However some infections can occur in the
opposite direction where bacteria enter the kidney via the blood stream. Such infections
are called hematogenous UTI (4).
3

The first line host defense mechanisms to kill bacteria and prevent their adhesion to
bladder mucosa include low pH, high salt, urea and organic acids in urine; bulk flow of
urine during micturition, mucin layer secreted by bladder transitional cells, Tamm
horsfall factor which can bind to type 1 fimbriae of UPEC and defensins which can
disrupt cell membrane of UPEC (11). Thus once inside the bladder, the bacterium has to
immediately adhere and invade the bladder epithelial cells to protect itself from the above
mentioned host defense mechanisms. Uropathogenic E. coli have the virulent factors
necessary to colonize the bladder successfully and evade the host immune response (4).
UPEC adhere to host uroepithelial cells using adhesins of various types, the 2 main being
type 1 fimbriae and P fimbriae. These adhesion molecules not only help in the attachment
of UPEC to superficial umbrella cells, but also stimulate the signaling pathways leading
to the invasion of bacteria into the urothelial cells (11, 16). After invasion, bacteria enter
a highly replicative phase forming a complex intracellular bacterial community (IBC)
which shows specific biofilm-like traits. Invasion of urothelial cells and formation of IBC
helps UPEC to escape host immune response and multiply in large numbers which are
difficult to be cleared completely by polymorphonuclear leukocytes (PMNs) (17).
Attachment of bacteria to the uroepithilial cells through FimH (type 1 fimbriae), and
release of bacterial toxins like HylA and CNF1 triggers exfoliation of the entire layer of
superficial bladder epithelial cells through a rapid apoptosis-like mechanism. This is
considered to be one of the host defense mechanisms to prevent UTI (11, 18). However
UPEC already multiplied into an IBC, flux out from the bladder cells to infect underlying
transitional epithelium and enter a quiescent intracellular non replicative phase which
forms a reservoir for future recurrent infections. This quiescent intracellular reservoir
4

(QIR) helps UPEC to persist in the urinary tract for months after initial infection and
resist systemic antibiotic therapy (19).
Other virulence factors expressed by UPEC include secreting toxins like α-hemolysin
(HylA), cytotoxic necrotising factor 1 (CNF1), secreted autotransporter toxin (SAT), etc.
These factors help UPEC to not only gain access to host nutrients and iron stores but also
to impair host immune response. Some of these toxins and virulence factors like LPS,
Type 1 or P fimbriae are recognized by TLR4 (Toll-like receptor 4) of urothelial cells and
stimulate the signaling pathway leading to the expression of IL-6 and IL-8 through NFkB dependent or independent pathways. IL-6 and IL-8 helps in neutrophil recruitment to
the site of infection to kill bacteria in the urinary tract (11, 20).
Importance of known osmoregulatory systems for the survival of UPEC in urine
Human urine is one of the first line host defense mechanisms against UTI. The
physicochemical stress imposed by urine to prevent E. coli colonization includes
fluctuating pH (5-8) and osmolality (0.04 mol/kg to 1.4 mol/kg), high urea levels (up to
0.5M) and a high concentration of organic acids (21-23). Despite these unfavorable
conditions, UPEC can still survive and grow in urine. Growth rate of uropathogenic and
non uropathogenic strains (fecal isolates) of E. coli are similar in urine. This indicates
that the survival of E. coli in urine is not a urovirulent trait (24, 25).
The 2 main physicochemical stresses imposed on E. coli in urine include osmotic stress
due to high concentration of inorganic salts and denaturing stress due to urea.
E. coli can sense an osmotic upshift in external medium through pressure sensors located
in the inner membrane; changes in intracellular water activity, pH and K+; and through
5

alterations in the protein-ligand or protein-protein interactions inside the cells as a result
of increased internal hydrostatic pressure (26). Accumulation of K+ and synthesis or
capture of glutamate to counteract alkalinization effects of K+ involves the initial
response to salt stress especially at low levels (26, 27). Under higher osmotic stress, low
molecular weight organic compatible solutes like glycine betaine, carnitine and proline,
etc. are preferred over salt accumulation, as they can be synthesized or accumulated at
high levels without effecting cellular processes (due to their high solubility and no net
charge at physiological pH). These compatible solutes provide osmoprotection by
destabilizing the partially denatured proteins and stabilizing their native conformations
(26, 28).
The stress imposed by urea is different from the osmotic stress imposed by NaCl or other
inorganic salts in urine, because urea can diffuse freely across the cell membrane and is a
protein denaturant (22, 29). It was initially believed that osmotic stress induced betain
accumulation protects the cell against the toxic effects of urea in urine. However, the lack
of betain accumulation did not affect the growth rate of CFT073 in urine (22, 23, 30).
Limited research has been conducted to determine the genes that protect UPEC against
high osmotic stress and denaturing stress in urine. A brief summary of the studies till date
is discussed in Table 1. Based on these studies, only proP showed an osmoprotective role
in HU734 (UPEC) to survive in urine; however it showed mixed results during in vivo
colonization of the murine urinary tract. In the case of CFT073 (UPEC), none of the
osmosystems studied till date was proved to be important for providing osmoprotection in
urine.
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Naturally occurring E. coli isolates express broad variations in osmotolerance (31).
CFT073 and HU734 are UPEC strains with CFT073 being more osmotolerant and
urovirulent compared to HU734 (22). Based on Table 1, it can be said that the
mechanism used by both strains to grow in urine might be different.
It was recently shown that OmpR is required for the survival of NU134 (UPEC) in urine
and to colonize murine urinary tract. OmpR-EnvZ is a two component regulatory system
that responds to osmotic stress. EnvZ senses the osmotic shock and gets
autophosphorylated which inturn phosphorylates OmpR. The phosphorylated OmpR acts
as a transcriptional activator or repressor and alters the expression of various genes
involved in osmotic tolerance, acid tolerance, outer-membrane proteins, type 1 pili and
virulence factors like IutA (32). However as E. coli isolates show broad variations in
osmotolerance, the role of OmpR is providing osmoprotection to CFT073 and other
UPEC strains in urine needs further confirmation. And the exact gene or the mechanism
through which OmpR showed the above osmoprotective property in NU134 needs to be
determined.
The osmoprotective property found in urine is greater than predicted based on the
concentration of betains in urine (29). In addition, most of the other known
osmoprotectants like proline, pipecolate, ectoine, dimethyl

glycine, sarcosine

carboxymethyl pyridinium, D-carnitine, L-carnitine, butyrobetaine, taurine, betonicin,
trigonelline and thiaproline failed to improve the osmotolerance of CFT073 ∆proP
∆proU (33), indicating that there might be an unknown osmoprotectant in urine that
provides osmoprotection to UPEC through a mechanism yet to be discovered.
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System

Function

Kdp and
Trk system

K+ uptake

ProP

ProU

OtsBA

Uptake of
osmoprotectants majorly
proline, glycine betaine
and ectoine
Uptake of
osmoprotectants majorly
glycine betaine, proline
betaine, carnitine,
choline and ectoine
Trehalose synthesis
(regulated by RpoS
sigma factor)

Importance in survival of UPEC in urine
HU734
CFT073
No sufficient in vitro and in vivo experiments conducted. But CFT073
and HU734 were able to tolerate upto 0.4 M NaCl in K5 medium
containing low K+ in micromolar concentrations indicating that these
systems might be dispensable under high osmotic conditions in urine.

References

(22, 26, 33)

(+) in vitro cultivation in urine,
(-/+) in vivo bladder colonization

(-) in vitro cultivation in urine,
(-) in vivo bladder colonization

(22, 23)

(-) in vitro cultivation in urine,
(-) in vivo bladder colonization

(-) in vitro cultivation in urine,
(-) in vivo bladder colonization

(22, 23)

RpoS variant in HU734 is
defective, leading to insignificant
trehalose accumulation under
osmotic stress

(-) in vitro cultivation in urine,
(-) in vivo bladder colonization

(22)

Proline is not an osmoprotectant for
CFT073 ∆proU ∆proP. Thus might
Proline uptake
(22, 23, 33)
PutPA
not be responsible for the
osmotolerance of CFT073 in urine.
betU was not selected among uropathogens during evolution based on
Betaine uptake
equal distribution of this gene among pathogenic and non-pathogenic
(33)
BetU
E.coli strains. betU is present in HU734 but absent in CFT073.
Choline uptake is higher in HU734 compared to CFT073 and was not
Uptake of Choline and
affected by the lack of proP or proU systems in both the strains. Thus
oxidation into glycine
(26, 33)
BetTBA
betT might not be responsible for the higher osmotolerance of CFT073
betaine
compared to HU734.
Table 1: Importance of known osmoregulatory systems in UPEC for survival in urine. In vitro and in vivo experiments are
(-) in vitro cultivation in urine,
(-) in vivo bladder colonization

conducted using null mutants of HU734 or CFT073 for that respective gene or system. (+) result indicate growth defect or impaired
colonization of murine bladder by the null mutant compared to its wild type and (-) result indicate no difference. For some genes
invitro or invivo experiments were not performed. But the information presented in the corresponding reference articles was
summarized to predict their potential role in the survival of HU734 or CFT073 in urine.

Previous work in Dr. Paliy’s lab
Considering that none of the known osmoregulatory systems are responsible for the
survival of uropathogenic E. coli in urine, especially in CFT073 (a highly virulent
pyelonephritis isolate), microarray experiments were performed to identify genes which
are differentially expressed in CFT073 during salt stress (0.3 M NaCl) and urea
stress (0.6 M urea) in K medium (osmolality is 0.15 osmol/kg H2O) at 30˚C. Osmolality
of K medium with 0.3 M NaCl is 0.65 osmol/kg H2O and it led to the over-expression of
osmotically inducible regulons like proU, kdpDE, betTIBA etc. most of which are not
induced during 0.6 M urea stress. However during the presence of 0.6 M urea in K
medium (0.65 osmol/kg H2O), expression of several genes with chaperone activity were
induced (34). Based on these results, bax, ibpAB and cspH were chosen for the present
study.
[CFT073 was chosen for the microarray experiments because it is a highly virulent
pyelonephritis isolate. Its whole genome is sequenced (35) and CFT073 specific DNA
microarrays were already created and available (36). K medium was used because it is a
low basal osmolality medium and to compare the results with previous study conducted
to observe the transcriptional response of commensal E. coli to salt stress (34, 37, 38)].
Bax
Bax is a hypothetical protein of unknown function. ORF of bax is 825 nt long and the
protein is made of 274 aa (BioCyc database). The promoter region of bax is predicted to
be regulated by sigma 70 based on computational analysis (39).
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Gene
Name
Bax
IbpA
IbpB
CspH

Log signal
K1
6.5
8.6
5.3
2.6

K2
5.7
8.5
5.2
4.3

K3
6.4
8.7
5.5
3.4

N1
9.0
8.8
5.8
4.1

N2
9.1
8.9
5.6
4.4

N3
8.9
8.7
6.0
2.9

U1
7.4
9.8
8.3
6.6

U2
7.6
10.1
8.4
6.7

U3
7.5
10.1
8.3
6.1

Average expression
ratio in NaCl versus
control
6.6
1.1
1.4
1.3

Average expression
ratio in urea versus
control
2.4
2.7
8.2
8.4

Table 2: Log signal values of bax, ibpA, ibpB and cspH gene expression in microarray experiments (34).
K1, K2, K3: Gene expression in 3 replicate cultures of CFT073 growing in K medium
N1, N2, N3: Gene expression in 3 replicates cultures of CFT073 growing in K medium with 0.3 M NaCl
U1, U2, U3: Gene expression in 3 replicates cultures of CFT073 growing in K medium with 0.6 M urea
Growth conditions used: A single colony of CFT073 strain was inoculated into liquid Luria-Bertani (LB) medium and grown
aerobically till saturation. Freshly made K medium was inoculated with an aliquot of above culture and grown till late log phase.
Aliquot of this culture was used to inoculate 3 flasks with 1/5th volume of K medium, K medium with 0.3 M NaCl and K medium with
0.6 M urea and grown in water bath shaker at 30˚C and 200 RPM till the cultures reached an OD 600 (optical density at 600 nm) of
0.45. Then cells were harvested and RNA was extracted to perform microarray experiments.
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Expression of bax was induced in CFT073 during the salt stress of 0.3 M NaCl in K
medium at 30˚C with an average expression ratio of 6.6 in NaCl-versus-control (34).
Overexpression of bax was also observed as a long term response to 0.3 M NaCl in
NCM3722 (E. coli K-12 strain) at 30˚C (38) and as an early response (within 9 min) to
0.4 M NaCl in MC4100 (E. coli K-12) at 37˚C (40).
Its overexpression was also noticed in acid treated E. coli O157:H7 during in vitro
conditions suggesting its involvement in providing acid tolerance to enterohemorrhagic
E. coli (41).
Transcription of an alternative sigma factor rpoS was induced shortly after an osmotic
upshift (0.4 M NaCl) in MC4100 along with a broad set of genes whose expression
depends on RpoS (40). Expression of bax was also induced during those experiments and
thus the role of RpoS in regulating the expression of bax was studied in the current
project.
IbpA and IbpB
IbpA and IbpB are 16 kDa small heat shock proteins belonging to the ubiquitous family
of α-heat shock proteins. The expression of these genes is induced several hundred-fold
after heat shock. Extreme heat shock conditions lead to protein aggregation. IbpA and
IbpB change the physical property of these protein aggregates so that bichaperone
(Hsp70-Hsp100) mediated protein disaggregation and refolding becomes more efficient
(42, 43). However E. coli lacking ibpA and ibpB show growth defect, reduced viability or
increased protein aggregation only under extreme heat stress of 45˚C - 50˚C (44-46).
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During heat shock conditions, IbpA and IbpB undergo deoligomerization and form IbpAIbpB heterooligomer (47). Though IbpA and IbpB alone have the property of protein
disaggregation, the efficiency of the Hsp100-Hsps70 dependent protein reactivation
depends upon the disaggregation of protein aggregates carried out in the presence of both
IbpA and IbpB (42, 44, 48) in addition, IbpA is required for targeting IbpB to the
aggregated proteins (45).
Genes ibpA and ibpB belong to an operon, which is expressed by sigma 32 regulated
promoter region upstream ibpA ORF. The ORFs of ibpA and ibpB are separated by 112
bp and both the genes have their own ribosome binding sites. ibpA and ibpB share 57.5%
protein sequence identity and are believed to have originated from a duplication event.
Expression of ibpB is under the control of an additional weak sigma 54 regulated
promoter region present upstream ibpB ORF. This promoter region is also heat shock
inducible (49, 50).

(49)
The bicistronic ibpAB transcript made through sigma 32 promoter is cleaved into
monocistronic ibpA and ibpB transcripts by RNase E. RNaseE is also responsible for the
further degradation of ibpB transcript leading to the differential expression of ibpA and
ibpB. Translation of ibpA is also controlled by an RNA thermometer (structured mRNA
region at 5’UTR which inhibits translation by forming a fold that can block Shine-
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Dalgarno sequence at low temperature. However, this structure is melted during
temperature upshift, allowing the protein translation) (50).
During microarray experiments performed in Dr. Paliy’s lab, expression of ibpAB genes
was induced during 0.6 M urea stress in CFT073 with an average expression ratio of 4.7
in urea vs control (34). Expression of ibpAB genes was also induced in commensal E. coli
during inflammatory bowel disease (51); and in CFT073 and asymptomatic bacteriuria E.
coli strains 83972 and VR50 during biofilm growth in urine (52, 53).
Lack of ibpAB inhibits the formation of biofilm in E. coli (54). The hypercolonization
phenotype of CFT073 dsdA compared to wild type CFT073 was reduced by ibpB.
However CFT073 ibpB knockout did not show any colonization defects in murine urinary
tract (55).
CspH
CspH is a small protein made of 70 amino acids and belongs to the CspA family of cold
shock proteins. The exact function of CspH is still unknown. CspA family consists of 9
genes (CspA-I), with different functions and only some of them are cold shock inducible.
However they all have conserved β-barrel structure and most of them possess the
property of binding to ssRNA and ssDNA (but not dsDNA) though a high degree of
RNA/DNA substrate specificity is not apparent (56-58).
One of the deleterious effects of cold shock is stabilization of DNA and RNA secondary
structures which affects transcription and translation by hindering the moment of RNA
polymerase and ribosomes. CspA and its homologues act as RNA chaperones by melting
these secondary structures and enabling transcription and translation.
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The β-barrel structure of Csp proteins is made of 5 antiparallel β strands with two RNA
binding motifs RNP1 and RNP2 on β2 and β3 strands, respectively. Due to electrostatic
attraction, RNA approaches the Csp protein and intercalates between the aromatic
residues present on the protein surface at RNP1 and RNP2 sites. However due to the
overall negative charge on the protein surface (except at the RNP sites), limited
intramolecular and intermolecular base pairing occurs with a segment of RNA
undergoing charge repulsion. This was the mechanism proposed for the chaperone
activity of CspA and its homologues. Systematic studies on CspE amino acid sequence
revealed that Phe17, Phe30 and His32 are required for the nucleic acid melting activity
with Phe initiating the process and His ending it. When these amino acids were
substituted by Arg, the protein retain the property of binding to nucleic acids but lost the
ability to melt secondary structure. Interestingly, CspH protein does not have Phe17 and
Phe30 in its RNA binding sites. They are substituted with Lysine and Glutamine
respectively (59, 60).
Though the β-barrel structure of the CspA family is well conserved in CspH, it shows
some unique features like having four aromatic amino acids in its peptide sequence with a
high isoelectric point of ~10.72, compared to other CspA homologues found in E. coli
which have eight aromatic residues in their amino acid sequence and a low isoelectric
point ranging from 5 to 7.5. Thus it is possible that CspH might preferentially bind DNA
than RNA (60).
Expression of cold shock genes at lower temperatures is regulated at the level of
transcription, mRNA stability and translation, through regulatory elements which include
Downstream Box (DB), UP element and Cold Box in the 5’-UTR (59-61). In Salmonella
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enterica Serovar Typhimurium, cspH gene is cold shock inducible and is expressed at
37°C. Its cspH mRNA contains a short 23bp 5’-UTR and a well conserved 14-base DB
sequence. However as there is only 51.2% homology in the promoter regions of cspH in
Salmonella and E.coli, the expression of this gene in E. coli might be different. But
amino acid sequences showed a homology of 84.3% indicating that the cspH protein
function might be similar in both strains (60, 62). The promoter region of cspH also
possesses a consensus sequence for heat shock genes particularly at -10 region though an
induction in its expression at high temperatures is not observed (60).
Expression of cspH was induced in CFT073 during 0.6 M urea stress in microarray
experiments, with an average expression ratio of 8.4 in urea vs control (34). Expression
of cspH was induced 57 fold in asymptomatic bacteriuria E. coli strains 83972 and VR50
during biofilm growth compared to planktonic growth in urine (53). Overexpression of
cspH and ibpAB genes was also observed in the antibiotic resistant bacterial persisters
which exhibit multidrug tolerance (63).
RpoS sigma factor
Alternative sigma factor, RpoS is one of the bacterial transcription initiation factors that
directs the RNA polymerase to bind to specific gene promoters. It expected to regulate
the expression of about 10% genes in E. coli that are involved in stress response and
providing tolerance against conditions like osmotic stress, acid stress, oxidative stress,
during stationary phase and non-optimal growth conditions (22, 64).
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Overview of the current project
Role of bax, ibpAB and cspH genes in CFT073 to provide protection against salt and urea
stress was studied in the current project. First conservation of each gene among 3
different UPEC strains and in MG1655 (K-12 strain) was examined and GFP
transcriptional fusion plasmids were constructed to test if the expression of these genes is
induced in CFT073 during high levels of salt or urea. Role of RpoS sigma factor in
regulating the expression of these genes during salt or urea stress was also investigated.
Based on these results, growth curve experiments were performed with bax, ibpAB and
cspH knockouts of CFT073 and/or BW25113 (K-12) under salt or urea stress to
determine if these strains show any reduction in salt or urea tolerance compared to their
respective wild type strains.
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HYPOTHESIS AND SPECIFIC AIMS
Hypothesis: In CFT073, expression of bax is up regulated under salt stress and deletion
of bax will reduce the salt tolerance of CFT073 and BW25113 (K-12). Expression of
ibpAB and cspH is induced during urea stress and lack of either of these genes will lead
to reduced urea tolerance of CFT073 and/or BW25113.
Specific aim 1: Test if expression of bax is induced under salt stress in CFT073 and if
lack of bax will reduce the salt tolerance of CFT073 and BW25113.
-

Aim 1a) Examine the sequence conservation of bax and its promoter region in
CFT073, UTI89, E. coli 536 and K-12 strains.

-

Aim 1b) Test if expression of bax is induced under salt stress and if RpoS
regulates the expression of bax in CFT073.

-

Aim 1c) Test if deletion of bax gene reduces the salt tolerance of BW25113 and
CFT073.

Specific aim 2: Test if expression of ibpAB operon is induced under urea stress in
CFT073 and if lack of ibpAB operon will reduce the urea tolerance of CFT073 and
BW25113.
-

Aim 2a) Examine the sequence conservation of ibpAB operon and its promoter
region in CFT073, UTI89, E. coli 536 and K-12 strains.
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-

Aim 2b) Test if expression of ibpAB operon is induced under urea stress and if
RpoS regulates the expression of ibpAB operon in CFT073.

-

Aim 2c) Test if deletion of ibpAB operon reduces the urea tolerance of CFT073
and BW25113.

Specific aim 3: To test if expression of cspH is induced under urea stress in CFT073
and if lack of cspH leads to reduced urea tolerance of BW25113.
-

Aim 3a) Examine the sequence conservation of cspH and its promoter region in
CFT073, UTI89, E. coli 536 and K-12 strains.

-

Aim 3b) Test if expression of cspH is induced under urea stress and if RpoS
regulates the expression of cspH in CFT073.

-

Aim 3c) Test if deletion of cspH reduces the urea tolerance of BW25113.
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MATERIALS AND METHODS
Bacterial strains, plasmids and media. All strains and plasmids used in the
current study are listed in Tables 3 & 4. The media used include liquid LB medium (10
g/liter tryptone, 10 g/liter NaCl, and 5 g/liter yeast extract), 1.5% LB agar plates, K
medium (1 mM KH2PO4, 1 mM (NH4)2SO4, 0.08 mM MgCl2 · 6H2O, 1.8 µM Fe2SO4 ·
7H2O, 0.5% casamino acids, and 10 mM glucose) (37), 1.5% K medium agar plates and
M9 medium (47.7 mM Na2HPO4.7H2O, 22 mM KH2PO4, 8.55 mM NaCl, 18.7 mM
NH4Cl, 2 mM MgSO4, and 0.1 mM CaCl2 per liter supplemented with 0.2% casamino
acids and 0.4% or 22.2 mM glucose) (65, 66). Kanamycin (50 µg/ml), ampicillin (200
µg/ml) and chloramphenicol (35 µg/ml) were added to the medium and LB agar plates
when necessary.
Primer Design. All the oligonucleotide primers used in the present project are
listed in Table 5. They were designed using IDT OligoAnalyzer and FastPCR. Primer
specificity was checked using NCBI Primer-BLAST and primers were obtained from
Integrated DNA technologies (Coralville, IA).
Plasmid construction. Taq 2X Master Mix, T4 DNA ligase and restriction
enzymes were obtained from New England Biolabs (Beverly, MA). Purification of
plasmid DNA, genomic DNA and PCR products; and gel extractions were performed
using spin column kits from Qiagen (Hilden, Germany). For the construction of bax,
ibpAB and cspH transcriptional fusion plasmids E. cloni 10G chemically competent cells
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(Lucigen, Middleton, WI) was used as the host strain. All the remaining transformations
were performed directly into CFT073 using ligated DNA without any intermediate host.
pBax, pIbpAB, pCspH: CFT073 genomic DNA was used as a template to amplify
bax promoter region using Bax-GFP-Fwd and Bax-GFP-Rev primers; ibpAB promoter
region using IbpAB-GFP-Fwd and IbpAB-GFP-Rev primers; and cspH promoter region
using CspH-GFP-Fwd and CspH-GFP-Rev primers with the help of Taq 2X Master mix
(New England Biolabs). The amplified PCR products were digested with BamHI and
XhoI, and cloned into pUA139 vector (67) previously linearized with the same restriction
enzymes. The ligated DNA was used to transform E. cloni 10G chemically competent
cells (Lucigen) according to the manufacturer’s instructions. The plasmid DNA was
isolated and the inserted promoter regions upstream GFPmut2 were sequenced using Seqprimer through CGR sequencing facility (Wright State University, Dayton, OH).
pAL139-CspH: The copy number of cspH promoter fusion plasmid was increased
from ~5 to 50-70 copies per cell by replacing pSC101 origin of replication in pCspH
plasmid to ColE1 origin from pZE21 plasmid (68). Plasmids, pZE21 and pCspH were
digested with BglII and AvrII. The DNA fragment containing cspH promoter region and
GFP from pCspH plasmid was gel extracted and ligated to the gel extracted DNA
fragment containing ColE1 origin and kanamycin resistance marker from pZE21 plasmid.
pAL139-IbpAB: Promoter region of ibpAB is amplified from CFT073 genomic
DNA using IbpAB-GFP-Fwd and IbpAB-GFP-Rev primers and digested with XhoI and
BamHI. Plasmid pAL139-CspH is also digested with BamHI and XhoI and the pAL139
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vector was gel extracted. The digested ibpAB promoter region was cloned into the gel
extracted pAL139 vector to produce pAL139-IbpAB plasmid.
pAL139 vector: 5’ phosphorylated primers, pAL139-Fwd and pAL139-Rev each
at a final concentration of 10 ng/µl are added to 50 µl of 1X T4 DNA ligase buffer. The
sample was kept at 95˚C for 2 min and cooled to 25˚C over a period of 45 min for the
oligos to anneal. The annealed oligos form a 24 bp insert with BamHI and XhoI sticky
sites on opposite ends, which was subsequently cloned into BamHI and XhoI digested
pCspH-HC plasmid (after separating the cspH promoter region through gel extraction)
using T4 DNA ligase.
pDOC-Bax: Bax-Null-Fwd and Bax-Null-Rev primers were used to amplify
kanamycin resistance cassette from BW25113 ∆bax genomic DNA using Taq 2X Master
Mix. The amplified PCR product contained the following regions:
EcoRI site – H1 – GACCGGTCAATTGGCTGGAG – Flp1 site – Kanamycin cassette –
Flp 2 site – GGAACTAAGGAGGATATT- H2 - NheI site
H1: 35 nt of sequence homologous to the bax start codon and 32 nt upstream to it.
H2: 52 nt of sequence homologous to the 21 nt of bax C-terminal region, bax stop codon
and 28 nt downstream to it.
The PCR product was digested with EcoRI and NheI and cloned into pDOC-C linearized
with EcoRI and NheI restriction enzymes.
pDOC-IbpAB: IbpAB-Null-Fwd and IbpAB-Null-Rev primers were used to
amplify kanamycin resistance cassette from pKD13 plasmid (69) using Taq 2X Master
Mix. The amplified PCR product contained the following regions:
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EcoRI site – H1 – GACCGGTCAATTGGCTGGAG – Flp1 site – Kanamycin cassette –
Flp 2 site – GGAACTAAGGAGGATATT- H2 - NheI site
H1: 28 nt of sequence homologous to the ibpA start codon and 25 nt upstream to it.
H2: 28 nt of sequence homologous to the 3 nt of ibpB C-terminal region of, ibpB stop
codon and 22 nt downstream to it. The PCR product was cloned into pDOC-C vector to
construct pDOC-IbpAB plasmids using EcoRI and NheI restriction sites.
Electroporation. All strains were transformed through electroporation during the
current project except E. cloni 10G chemically competent cells.
Preparation of electrocompetent cells: A single fresh colony of the desired strain
was inoculated in 50 ml LB medium in a 500 ml flask and grown with vigorous aeration
overnight at 37°C. 100 ml of LB in 500 ml flask was inoculated with 0.1 ml of the
overnight grown culture and grown at room temperature with vigorous aeration till the
culture reached an OD600 of 0.4 – 0.6 OD. The culture was kept on ice for 25 minutes
and the cells were harvested by centrifugation at 2600 x g for 15 minutes. Cell pellet was
washed twice with ice cold 10% glycerol and resuspended in 1 ml of ice cold 10%
glycerol. The 25 µl aliquots were made for the resuspended cells, snap frozen and stored
at -80C.
Electroporation: CFT073, DH5α and BW25113 were transformed with ligated
DNA or plasmid sample through electroporation using Cell-Porator and Voltage booster
according to the manufacturer’s instructions (GIBCO/BRL). Briefly 1.25 µl of the ligated
DNA or plasmid sample was added to 25 µl of electrocompetent cells and suspended
between the electrode bosses of 0.15 cm micro-electroporation chamber. An electric
pulse was applied with a voltage of 2.4 kV and pulse length of 6 milliseconds. 1 ml of
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SOC medium was added to the cells and incubated at 37˚C with gentle shaking for 1
hour. 50 - 200 µl of culture was plated on LB agar plate with appropriate antibiotic to
select for transformants.
Construction of null mutants. Gene doctoring method (70) was used to construct
null mutants of CFT073 and BW25113. Figure 3.1 describes the construction of CFT073
∆bax using gene doctoring method. Briefly, a sucrose sensitive colony of CFT073 or
BW25113 containing pACBSCE and pDOC-Bax or pDOC-IbpAB plasmids was grown
in 1 ml LB medium supplemented with kanamycin (50 µg/ml), ampicillin (200 µg/ml),
chloramphenicol (35 µg/ml) and glucose (0.5%) for 2 hours at 37˚C. The cells were
harvested and resuspended in 1 ml of fresh LB medium containing 0.5% L-arabinose and
grown with vigorous aeration at 37˚C for 5 hours. Dilutions of the culture were plated on
LB agar plate containing kanamycin (50 µg/ml), 6% sucrose and no NaCl. The isolated
colonies were checked for the loss of pACBSCE and pDOC-Bax / pDOC-IbpAB plasmid
by patching onto LB plates containing chloramphenicol (35 µg/ml) and ampicillin (200
µg/ml) respectively. Nine colonies, which were sensitive to ampicillin and
chloramphenicol but resistant to sucrose and kanamycin, were further screened through
colony PCR. Colony PCR was performed using a forward primer (Bax-GFP-Fwd,
IbpAB-GFP-Fwd, CspH-GFP-Fwd) which binds upstream of the target region in CFT073
or BW25113 genome and the reverse primer (K1) that binds inside the kanamycin
cassette. The colony which gave desired PCR product was further tested through
additional colony PCR reactions with 3 different primer pairs as described below to
confirm the knockout.
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1. Forward primer which binds inside the kanamycin cassette (K2) and reverse
primer (Bax-ORF-Rev, IbpAB-ORF-Rev) which binds downstream of the target
region in CFT073 or BW25113 genome.
2. Forward (Bax-GFP-Fwd, IbpAB-GFP-Fwd) and reverse primers (Bax-ORF-Rev,
IbpAB-ORF-Rev) bind upstream and downstream of the target region
respectively in CFT073 or BW25113 genome.
3. Forward (Bax-RT-Fwd, IbpA-RT-Rev, CspH-RT-Fwd) and reverse primer (BaxqPCR-Rev, IbpA-qPCR-Rev, CspH-RT-Rev) bind inside the bax, ibpA or cspH
open reading frames and amplify a small region of 74-82 bp.
Colony PCR with 2nd and 3rd primer pairs was performed to confirm that the cells did not
retain the knocked out gene as a result of partial duplication in bacterial genome (71, 72).
During the construction of ibpAB null mutants of CFT073 and BW25113, pACBSR
plasmid (73) was used instead of pACBSCE plasmid, with a procedure being described
above. Plasmid pACBSR is similar to pACBSCE plasmid but with no SceI restriction
enzyme site. Thus the plasmid was retained in the final recombinant, which was cured or
removed through electroporation (74, 75).
Colony-PCR. A colony was picked using a sterile pipet tip and suspended in 20 µl
of DNase/RNase-Free water. The colony suspension was kept at 100˚C for 10 minutes,
then on ice for 2 min and centrifuged at maximum speed (18000 x g) for 5 minutes. 3 µl
of the supernatant was added to 10 µl of Taq 2X Master Mix, 1 µl of forward primer (10
µM, 1 µl of reverse primer (10 µM) and the volume was made upto 20 µl with sterile
water. PCR was performed using the appropriate annealing temperature and elongation
time depending upon the melting temperature of the primers and PCR product size.
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Promoter activity assay. A fresh single colony was inoculated into 3 ml of LB
medium and grown till saturation. 50 µl of the saturated culture was used to inoculate 5
ml of K medium and incubated over night at 37˚C. The culture was diluted in 200 µl of
fresh K medium to a final OD600 of 0.1 and grown in microplate reader (FLUOstar
OPTIMA) with shaking (orbital, 7 mm) till the cells reached an OD600 of 0.3. The cells
were diluted at 1:20 ratio in fresh K medium to a total volume of 200 µl and grown in the
microplate reader with absorbance (OD600) and fluorescence (Ex. 485 nm, Em. 530 nm)
measurements taken every 12 minutes. When the cells reached an OD600 of ~0.1, NaCl,
urea or sterile water were added to the appropriate wells, and absorbance and
fluorescence measurements were continued for the next 6-8 hours. Measurements were
blank corrected and graphs were plotted using Microsoft Excel. LB or K medium was
supplemented with kanamycin (50 µg/ml) when necessary. For each condition,
experiments were performed in triplicate.
Growth curve experiments. The protocol used for the growth curve experiments
was similar to that described for promoter activity assays, except for taking only
absorbance measurements (OD600) while the cells were growing in the microplate reader.
For each condition, experiments were performed in triplicate.
Streak plate experiments: A single fresh colony of the desired strain was picked
with a sterile loop and streaked on K medium 1.5% agar plates containing no urea, 0.3 M
urea or 0.6 M urea. The plates were incubated at room temperature, as urea degrades at
higher temperatures producing toxic products (76). Digital and fluorescence images were
taken after 48 and 96 hours of incubation to determine the growth and fluorescence of the
cells.
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Figure 3.1: Gene doctoring method to construct bax null mutant of CFT073. CFT073
wild type strain is transformed with pDOC-Bax plasmid (with kanamycin resistance
cassette flanked by 35 and 52 nt of bax upstream and downstream homologous regions
respectively) and pACBSCE plasmid. The culture was treated with 0.5% L-arabinose in
the exponential phase to induce the expression of I-SceI restriction enzyme and λ-Red
gene products. I-SceI restriction enzyme liberates the DNA fragment containing
kanamycin resistance cassette and bax flanking regions from the pDOC-Bax plasmid, that
later recombines with CFT073 genome using λ-Red system. An aliquot of the culture was
plated on LB kanamycin plate supplemented with 6% sucrose and incubated overnight at
30˚C. The colonies that grew were tested for ampicillin and chloramphenicol sensitivity
and screened by colony-PCR for the true recombinant.
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Strains

Description
F- endA1 hsdR17 (rk-, mk-) supE44 λ- thi-1 recA1 gyrA96 relA1
∆(argF- lacZYA) U169 y80d lacZDM15
F¯ mcrA ∆(mrr-hsdRMS-mcrBC) endA1 recA1 ᶲ80dlacZ∆M15
∆lacX74 araD139 ∆(ara,leu)7697 galU galK rpsL (StrR) nupGλ
tonA
Wild-type pyelonephritis isolate
CFT073 ∆rpoS2062
CFT073 bax::kan, Kanr

Reference or source

This study

BW25113 ∆bax

CFT073 ibpAB::kan, Kanr
∆(araD-araB)567, ∆lacZ4787(::rrnB-3), lambda-, rph-1,
∆(rhaD-rhaB)568, hsdR514
BW25113 bax::kan, Kanr

BW25113 ∆ibpAB

BW25113 ibpAB::kan, Kanr

This study

DH5α
E.cloni 10G
CFT073
CFT073 ∆rpoS
CFT073 ∆bax
CFT073 ∆ibpAB
BW25113

BW25113 ∆cspH

BW25113 cspH::kan, Kan

r

Lab strain
Commercial (Lucigen)
(77)
(22)
This study
Keio strain (80)
Keio strain (80)
Keio strain (80)

Table 3: Strains used
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Reference or
source
(67)

Plasmids

Description

pUA139

GFP transcriptional fusion plasmid, promoter less, pSC101 ori, Kanr

pBax

GFP transcriptional fusion plasmid for bax promoter, pSC101 ori, Kanr

pIbpAB

This study

GFP transcriptional fusion plasmid for ibpAB operon promoter, pSC101 ori, Kan

r

r

This study

pCspH

GFP transcriptional fusion plasmid for cspH promoter, pSC101 ori, Kan

This study

pZE21

GFPaav reporter plasmid, ColE1 ori, Kanr

(68)

pAL139

GFP transcriptional fusion plasmid, promoter less, ColE1 ori, Kanr

pAL139-CspH
pAL139-IbpAB

This study

GFP transcriptional fusion plasmid for cspH promoter, ColE1 ori, Kan

r

This study

GFP transcriptional fusion plasmid for ibpAB operon promoter, ColE1 ori, Kan

r

r

This study

pBax-ORF

Encodes bax gene under the control of its native promoter, pSC101 ori, Amp

pIbpAB-ORF

This study

pACBSR

Encodes ibpAB operon under the control of its native promoter, pSC101 ori, Ampr
Kanamycin cassette flanked by bax upstream and downstream homologoues regions,
SacB, I-SceI site, pMBI ori , oriT, Ampr
Kanamycin cassette flanked by ibpA upstream and ibpB downstream homologous regions,
SacB, I-SceI site, pMBI ori , oriT, Ampr
λ-Red recombinase, endonuclease I-SceI, Cmr

pACBSCE

λ-Red recombinase, endonuclease I-SceI, I-SceI site, Cmr

(70)

pDOC-C

Cloning plasmid for Gene doctoring system, pMBI ori , oriT, Ampr

pDOC-Bax
pDOC-IbpAB

pKD13

Template plasmid used to construct pDOC-IbpAB, FRT-flanked Kan , Amp
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This study
This study
(73)
(70)

r

Table 4: Plasmids used

This study

r

(69)

Primer
Bax-GFP-Fwd
Bax-GFP-Rev
IbpAB-GFP-Fwd
IbpAB-GFP-Rev
CspH-GFP-Fwd
CspH-GFP-Rev
Seq-primer
Seq-GFP
Fwd-pAL139 (5' phosphorylated)
Rev-pAL139 (5' phosphorylated)
Bax-ORF-Rev
IbpAB-ORF-Rev
Bax-Null-Fwd
Bax-Null-Rev

Sequence (5'-3')
ACTCGTGGATCCTTATTAGAACCCCGGAGAAGTCCA
ATCAGCCTCGAGTTATTATGTTGTGTGCGTCTTCGC
ATCGTTGGATCCTTATTAGGTATGGGACATCACGCT
GCTACTCTCGAGTTATTAAAAACCAGCCACAGCGAT
GCTCGCGGATCCTTATTAAGTGAAATGGACGAAAACGTC
GCTATTCTCGAGTTATTAGCGTAATCCTGGTATAAGCAC
CACCTTCACCCTCTCCACTGACAG
TACTCAGGAGAGCGTTCACC
GATCCGATCTCTAGAATTCAGTCACTTC
TCGAGAAGTGACTGAATTCTAGAGATCG
TACATCTCTAGACGCATCAGGTAACTCAGCAC
ATACATTCTAGACAGGCGAAATTTAACGCATTG
ATGTTAGAATTCGTTGGAATGATTAAATCCGACCA
GACTATGCTAGCGACAAGTCGGATAAGGCTCA
ACTTATGAATTCTCGCTGATTTCAGGAGCTATTGATTA
IbpA-Null-Fwd
TGATTCCGGGGATCCGTCGACC
GACTATGCTAGCGCGGGGCAAAGAGAATAGCTAGTTA
IbpB-Null-Rev
GCTTGTAGGCTGGAGCTGCTTCG
K1 (69)
CAGTCATAGCCGAATAGCCT
K2 (69)
CGGTGCCCTGAATGAACTGC
Bax-RT-Fwd
CAATACGCACCCGGCTTACT
Bax-RT-Rev
TGTGGCAGTCACTTCCTGATC
IbpA-RT-Fwd
TACCGCCCAGGATAATCTGCT
IbpA-RT-Rev
GGTACAGATAGGTGCGCTCTT
CspH-RT-Fwd
TCCGACGGTCGTAAAGAAGTC
CspH-RT-Rev
CGCGTAATCCTGGTATAAGCAC
Table 5: Primers used. *Restriction sites are underlined.
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RESULTS
Aim 1:
Conservation of bax and its promoter region in K-12 and 3 different UPEC strains
Presence of bax was identified in 3 different UPEC strains, CFT073 (pyelonephritis
isolate) (77), UTI89 (cystitis isolate) (78) and E. coli 536 (pyelonephritis isolate) (79) and
in commensal E. coli MG1655 (K-12 strain) using BioCyc database as shown in the
Figure 4.1.
(CFT073, accession NC_004431.1; UTI89, accession NC_007946.1; E. coli 536,
accession NC_008253.1; MG1655, accession U00096.2)

Figure 4.1: Image showing bax and its upstream and downstream regions in
MG1655, E. coli 536, CFT073 and UTI89 genomes. The image was generated using
Multi-Genome Browser in BioCyc database (Image not to scale).
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Bax is a hypothetical protein, whose expression and function have not been studied in
detail. Though sigma 70 regulated promoter region has been identified for bax with
transcriptional start sites located at -57 nt and -44 nt upstream to the start codon of bax
ORF, it was based on computational analysis with no experimental evidence (39).
Between bax and malS there is an ORF for a hypothetical protein, the existence of which
is questionable. Hence for the present study, the intergenic region between bax and malS
along with 50 - 100 bp upstream and downstream to it was chosen to contain the bax
promoter region (67).
Before designing primers to amplify bax promoter region, nucleotide sequences
containing bax ORF and 400 nt upstream to it were collected for MG1655, CFT073, E.
coli 536 and UTI89 strains from BioCyc database and multialigned using ClustalW. The
results (Figure 4.1.2) showed pairwise scores ranging from 98-100%. The 1-2% single
nucleotide changes in the bax ORF among these 4 strains were silent mutations with no
change in the protein sequence, indicating that bax is a well conserved gene and its
expression and function might be similar among these 4 strains.
Expression of bax is induced under salt stress and is not regulated by RpoS sigma
factor in CFT073
The GFP transcriptional fusion plasmid for bax promoter region was constructed by
amplifying -394 nt to +96 nt relative to the bax start codon from CFT073 genomic DNA
and cloning into pUA139 vector, upstream from the strong ribosome binding site of
GFPmut2. The plasmid was transformed into CFT073 and promoter activity assays were
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performed as described in the Methods section. CFT073 transformed with pUA139
plasmid (promoter less GFP) was used as a negative control during these experiments.
To determine if the expression of bax is induced during salt stress, CFT073 strain
containing pBax plasmid was grown in a microplate reader untill exponential phase and
0.2 M and 0.3 M NaCl were added. The growth was continued in the microplate reader
with absorbance and fluorescence measurements taken every 12 minutes. The
measurements were blank corrected and graphs of RFU, OD600 and RFU/ OD600 against
time were plotted. Results (Figure 4.3) suggest that the expression of GFP (regulated by
bax promoter) was induced significantly in CFT073 due to the addition of 0.2 M and 0.3
M NaCl to the K medium and the level of induction was proportional to the amount of
NaCl added to the medium.
In the current project, the role of RpoS in regulating the expression of bax during osmotic
upshift was studied by transforming rpoS null mutant of CFT073 (kind gift from Dr.
Janet Wood, University of Guelph, Canada) with pBax plasmid and performing the
promoter activity assays as described above. Results (Figure 4.4) showed that the
expression of GFP from pBax plasmid in CFT073 wild type and ∆rpoS null mutant was
similar with no difference in the level of GFP expression before and after the addition of
0.3 M NaCl to the K medium. These indicate that the expression of bax during salt stress
is not regulated by RpoS sigma factor in CFT073.
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Figure 4.2: The multialignment results of bax ORF and 400 nt upstream of it in
CFT073, MG1655, UTI89 and E. coli 536 genomes. The multialignment results were
represented with the sequence of CFT073; nucleotides that differed in at least 2 of the 4
strains a indicated as uncolored bases. The forward and reverse primers (Bax-GFP-Fwd
and Bax-GFP-Rev) used to amplify bax promoter region from CFT073 genome are
underlined. ORF of bax is shown as a white text in the above sequence from 401 nt to
1225 nt. Image was created using ClustalW multialignment results and Jalview.
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Figure 4.3: Expression of GFP from bax promoter in pBax plasmid during salt
stress in K medium. CFT073 strain containing pBax plasmid or pUA139 vector plasmid
(negative control) were grown in microplate reader in K medium till exponential phase
and 0.2 M NaCl, 0.3 M NaCl or equal volumes of sterile water were added. The
absorbance (OD600) and fluorescence measurements were taken every 12 minutes before
and after the addition of NaCl and graphs of RFU, OD600 and RFU/ OD600 against time
were plotted. (A) RFU/ OD600, (B) RFU and (C) OD600 measurements. Each data point
represent mean + SEM of 3 independent experiments from one culture.
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Figure 4.4: Effect of RpoS on bax promoter activity during salt stress in CFT073.
CFT073 and CFT073 ∆rpoS strains transformed with pBax plasmid were grown in
microplate reader till exponential phase in K medium and 0.3 M NaCl or equal volumes
of sterile water were added. CFT073 (pUA139 vector) was used as a negative control and
treated similar to other cultures. The absorbance and fluorescence measurements were
taken every 12 minutes before and after the addition of NaCl and graphs were plotted.
(A) RFU/ OD600, (B) RFU and (C) OD600 measurements. Each data point represent mean
+ SEM of 3 independent experiments from one culture.
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Deletion of bax reduced the salt tolerance of BW25113 but had no effect on CFT073
In the current project, the role of bax in providing salt tolerance was compared in
CFT073 and BW25113 (K-12 strain) by using bax null mutant of each strain. CFT073
null mutant of bax was constructed using gene doctoring method (Lee et al. 2009) as
described in methods section. BW25113 ∆bax and BW25113 ∆cspH, Keio strains (80)
were obtained as a kind gift from Dr. Gyaneshwar Prasad (University of Wisconsin,
Milwaukee). Colony PCR was performed using at least 2 different primers pairs (K1, K2,
Bax-GFP-Fwd, Bax-ORF-Rev, Bax-RT-Fwd and Bax-RT-Rev) to confirm the bax
knockout in CFT073 (Figure 4.5) and BW25113 (Figure 4.6) as described in the Methods
section.
It was noticed that BW25113 shows a growth defect in K medium. Therefore growth
curve experiments to study the salt tolerance of CFT073 and BW25113 bax null mutants
were performed in M9 minimal medium which has been previously used to study osmotic
systems in BW25113. The osmolality of M9 medium used in the current project would be
around 240 mosmol/kg H2O (66, 81, 82). Results (Figure 4.7) showed that BW25113
∆bax has reduced salt tolerance compared to its wild type strain in the presence of 0.6 M
NaCl in M9 medium. However CFT073 wild type and its bax null mutant showed similar
salt tolerance in M9 medium with 0.6 M NaCl.
The growth curve experiments were repeated in K medium for CFT073 and CFT073
∆bax using 0.6 M NaCl. But once again no difference was observed in the salt tolerance
of CFT073 wild type and its bax null mutant (Figure 4.8).

36

Figure 4.5: Confirmation of bax knockout in CFT073 by colony PCR. Colony PCR
was performed for CFT073 ∆bax and CFT073 WT strains, using 4 different primers pairs
(K1, K2, Bax-GFP-Fwd, Bax-ORF-Rev, Bax-RT-Fwd and Bax-RT-Rev) as shown by the
graphic images above the electrophoresis gel images. Lane M shows DNA ladder, Lane
1 shows the colony PCR reaction results of CFT073 WT and Lane 2 shows the colony
PCR reaction results of CFT073 ∆bax (Graphic images are not to scale).
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Figure 4.6: Confirmation of bax knockout in BW25113 (Keio strain) by colony
PCR. Colony PCR was performed for BW25113 ∆bax and BW25113 WT strains using 2
different primer pairs (K1, Bax-GFP-Fwd, Bax-RT-Fwd, Bax-RT-Rev) as shown by the
graphic images above the electrophoresis gel images. Lane M shows DNA ladder, Lane
1 shows the colony PCR reaction results of BW25113 wild type and Lane 2 shows the
colony PCR reaction results of BW25113 ∆bax (Graphic images are not to scale).
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Figure 4.7: Effect of bax knockout on the growth rate of CFT073 and BW25113
during salt stress in M9 medium. 0.6 M NaCl or equal volumes of sterile water were
added to exponentially growing wild type and the bax knockout strains of BW25113 (A)
and CFT073 (B) in M9 medium. The absorbance measurements (OD600) were taken
every 12 minutes before and after the addition of NaCl and graphs were plotted. Error
bars represent mean + SEM among 3 replicates of each culture.
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Figure 4.8: Effect of bax knockout on the growth rate of CFT073 during salt stress
in K medium. NaCl (0.6 M) or equal volumes of sterile water were added to
exponentially growing wild type and bax null mutant of CFT073 in K medium. The
absorbance measurements (OD600) were taken every 12 minutes before and after the
addition of NaCl and graphs were plotted. Each data point represent mean + SEM of 3
independent experiments from one culture.
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Aim 2:
Conservation of ibpAB operon in K-12 and 3 different UPEC strains (CFT073,
UTI89 and E. coli 536)
Operon, ibpAB is present in MG1655 (K-12), CFT073, UTI89 and E. coli 536, which was
identified using BioCyc database as shown by the Figure 5.1. There is a difference in the
annotation of start codon for ibpA and ibpB ORF among these 4 strains in BioCyc
database. For CFT073 and UTI89 ibpA ORF starts from TTG codon and for MG1655 and
E. coli 536, it starts from ATG codon (Figure 5.2). The distance between these 2 codons
is only 3 bp. For ibpB, the ORF starts with first ATG start codon for CFT073 and second
ATG start codon for the remaining 3 strains. The distance between these 2 ATG start
codons is 3 bp (Figure 5.2).

Figure 5.1: Image showing ibpAB and its upstream and downstream regions in
MG1655, E. coli 536, CFT073 and UTI89 genomes. The image is generated using
Multi-Genome Browser in BioCyc database (Image not to scale).
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To test the sequence conservation of ibpAB operon among these 4 strains, the nucleotide
sequence of ibpA and ibpB open reading frames along with the intergenic region between
them plus 400 - 406 nt upstream to the start codon of ibpA was collected from BioCyc
database for CFT073, UTI89, E. coli 536 and MG1655 strains, and multialigned using
ClustalW. The results showed pairwise score of 99% (Figure 5.2). The 1% single
nucleotide changes were silent mutations with no change in the IbpA and IbpB protein
sequences. Based on the multialignment results, it is clearly evident that the ibpAB
operon is well conserved among the 3 UPEC and K-12 strain indicating a high possibility
of similar expression and function among the 4 strains.
Because ibpAB operon and its expression is well studied, the region -383 nt to +174 nt
relative to the start codon of ibpA ORF in CFT073 genome was amplified using IbpABGFP-Fwd and IbpAB-GFP-Rev primers and cloned into pUA139 vector upstream to the
ribosome binding site of GFPmut2. The resulting plasmid is named pIbpAB plasmid. The
amplified region contains the sigma 32 regulated promoter region of ibpAB operon,
which includes -10 and -35 regions, and transcriptional start site located -90 nt relative to
the start codon of ibpA ORF in CFT073.
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Figure 5.2: The multialignment results of ibpA and ibpB ORFs, intergenic region
and 400-406 nt upstream to the start codon of ibpA in CFT073, MG1655, UTI89 and
E. coli 536 genomes. The multialignment results were represented with the sequence of
CFT073; nucleotides that differed in at least 2 of the 4 strains are indicated as uncolored
bases. The forward and reverse primers (IbpAB-GFP-Fwd and IbpAB-GFP-Rev) used to
amplify ibpAB promoter region from CFT073 genome are also indicated with red
underline. Sequence in white text from 401 nt - 820 nt is ibpA ORF and 926 nt - 1360 nt
is ibpB ORF. The 2 start codons for ibpA and ibpB ORFs are underlined in green. Image
is created using ClustalW multialignment results and Jalview.
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Expression of ibpAB is induced during urea stress and is not regulated by RpoS
sigma factor in CFT073
To determine ibpAB promoter activity during urea stress, CFT073 strain was transformed
with pIbpAB plasmid and promoter activity assays were performed as described in the
Methods section using 0.3 M and 0.6 M urea. CFT073 with pUA139 plasmid was used as
a negative control and treated similar to test cultures.
Results (Figure 5.3) indicate that ibpAB promoter activity in CFT073 was induced due to
the presence of 0.3 M and 0.6 M urea in K medium. The induction in the promoter
activity was higher in the presence of 0.6 M urea compared to 0.3 M urea. Hence, it can
be concluded that the expression of ibpAB operon is induced due to the presence of urea
in K medium and the rate of induction depends upon the extent of urea stress.
To test if expression of ibpAB operon is regulated by RpoS sigma factor, CFT073 ∆rpoS
strain was transformed with pIbpAB plasmid and promoter activity assay was repeated.
Results (Figure 5.4) showed no significant difference in the expression of GFP from
pIbpAB plasmid in CFT073 wild type and rpoS null mutant in the absence or presence of
urea stress suggesting that the expression of ibpAB is not regulated by RpoS sigma factor.
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Figure 5.3: Expression of GFP from ibpAB promoter in pIbpAB plasmid during
urea stress in K medium. CFT073 strains containing pIbpAB plasmid or pUA139
vector plasmid (negative control) were grown in microplate reader till exponential phase
in K medium and 0.3 M urea, 0.6 M urea or equal volumes of sterile water were added.
The absorbance (OD600) and fluorescence measurements were taken every 12 minutes
before and after the addition of urea and graphs were plotted. (A) RFU/ OD600, (B) RFU
and (C) OD600 measurements. Each data point represent mean + SEM of 3 independent
experiments from one culture.
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Figure 5.4: Effect of RpoS on ibpAB promoter activity during urea stress in
CFT073. CFT073 and CFT073 ∆rpoS strain with pIbpAB plasmid were grown in
microplate reader till exponential phase in K medium and 0.3 M urea, 0.6 M urea or
equal volumes of sterile water were added. CFT073 (pUA139 vector) was used as a
negative control and treated similar to other cultures. The absorbance (OD600) and
fluorescence measurements were taken every 12 minutes before and after the addition of
urea and graphs were plotted. (A) RFU/ OD600, (B) RFU and (C) OD600 measurements.
Each data point represent mean + SEM of 3 independent experiments from one culture.
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Lack of ibpAB operon did not affect the urea tolerance of BW25113 and CFT073.
To determine the importance of ibpAB in providing protection against urea stress in
E.coli, ibpAB null mutants of BW25113 and CFT073 were constructed using gene
doctoring method (Lee et al. 2009) as described in the Methods section. The null mutants
were confirmed through colony PCR using 4 different primer pairs (K1, K2, IbpAB-GFPFwd, IbpAB-ORF-Rev, IbpA-RT-Fwd and IbpA-RT-Rev) (Figure 5.5).
Because BW25113 showed reduced growth rate in K medium, growth curve experiments
were performed in M9 medium using 0.9 M urea. Results (Figure 5.6) showed no
difference in the growth rate of ibpAB null mutants compared to their respective wild
type strains in the absence and presence of 0.9 M urea in M9 medium. Similar results
were obtained when the experiment was repeated for CFT073 WT and its ibpAB null
mutant in K medium (Figure 5.7).
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Figure 5.5: Confirmation of ibpAB knockout in CFT073 and BW25113 by colony
PCR. Colony PCR was performed for WT and ibpAB knockout strains of CFT073 and
BW25113 using 4 different primers pairs (K1, K2, IbpAB-GFP-Fwd, IbpAB-ORF-Rev,
IbpAB-RT-Fwd and IbpAB-RT-Rev) as shown by the graphic images above the
electrophoresis gel images. Lane M shows DNA ladder, Lane 1 shows the colony PCR
reaction results of CFT073 WT, Lane 2 for CFT073 ∆ibpAB, Lane 3 for BW25113 WT
and Lane 4 for BW25113 ∆ibpAB (Graphic images are not to scale).
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Figure 5.6: Effect of ibpAB knockout on the growth rate of CFT073 and BW25113
under urea stress in M9 medium. Urea (0.9 M) or equal volume of sterile water were
added to exponentially growing wild type and ibpAB knockout strains of BW25113 (A)
and CFT073 (B) in M9 medium. The absorbance (OD600) measurements were taken
every 12 minutes before and after the addition of urea and graphs were plotted. Each data
point represent mean + SEM of 3 independent experiments from one culture.
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Figure 5.7: Effect of ibpAB knockout on the growth rate of CFT073 during urea
stress in K medium. Urea (0.9 M) or equal volume of sterile water were added to
exponentially growing wild type and the ibpAB null mutant of CFT073 in K medium.
The absorbance (OD600) measurements were taken every 12 minutes before and after the
addition of urea and graphs were plotted. Each data point represent mean + SEM of 3
independent experiments from one culture.
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Aim 3:
Conservation of cspH gene in K-12 and 3 different UPEC strains (CFT073, UTI89
and E. coli 536)
Presence of cspH in MG1655 (K-12) and in UPEC strains CFT073, UTI89 and E. coli
536 was identified using BioCyc database (Figure 6.1). The expression and function of
cspH has not been studied in detail. The presence of sigma 32 (heat shock sigma factor),
sigma 24 (the extracytoplasmic / extreme heat stress sigma factor) and sigma 70
(housekeeping sigma factor) transcription initiation factor binding sites have been
identified upstream of cspH ORF. However, experimental evidence is lacking to confirm
that the expression of cspH is under the regulation of these sigma factors.

Figure 6.1: Image showing cspH and its upstream and downstream regions in
MG1655, E. coli 536, CFT073 and UTI89 genomes. The image is produced using
Multi-Genome Browser in BioCyc database. (Image not to scale)
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To test the sequence conservation of cspH among CFT073, UTI89, E. coli 536 and K-12
strains, cspH ORF and 400 nt upstream to the start codon of cspH ORF was collected for
these 4 strains from BioCyc database and multialigned using ClustalW. The results
showed a pairwise score of 98-100% (Figure 6.2). There is no difference in the protein
sequence among the 4 strains indicating that the 2% difference in nucleotide sequences
were silent mutations. Thus cspH is well conserved among these 4 strain and it’s
expression and function might be similar among them.

Figure 6.2: The multialignment results of cspH ORF and 400 nt upstream to it in
CFT073, MG1655, UTI89 and E. coli 536 genomes. The multialignment results were
represented with the sequence of CFT073; with nucleotides that differed in at least 2 of
the 4 strains as uncolored bases. The forward and reverse primers (CspH-GFP-Fwd and
CspH-GFP-Rev) used to amplify cspH promoter region from CFT073 genome are also
indicated with red underline. Part of the sequence in white text from 401 nt – 613 nt is
cspH ORF. The 14 bp downstream box, which is located +13 nt relative to the start
codon of cspH ORF is indicated with blue underline. Image is created using ClustalW
multialignment results and Jalview.
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Primers were designed to amplify -390 nt to + 150 nt relative to the start codon of cspH
ORF from CFT073 genome. This region was expected to capture all the transcription
regulator binding sites which regulate the expression of cspH along with DB or
downstream box (ATGACAGGAATTGT) located +13 nt relative to the start codon of
cspH ORF. PCR was performed to amplify cspH promoter region using these primers
(CspH-GFP-Fwd and CspH-GFP-Rev) with CFT073 genomic DNA as a template and
cloned into pUA139 vector.
Expression of cspH is induced during urea stress and is not regulated by RpoS
sigma factor in CFT073
Promoter acitivty assays were performed to test the activity of cspH promoter during urea
stress in CFT073. CFT073 (pCspH) and CFT073 with no plasmid (negative control) were
grown till exponential phase in K medium in microplate reader followed by which, 0.3 M
urea, 0.6 M urea or equal volumes of sterile water were added. Asorbance and
fluorescence meaurements were taken every 12 min before and after the addition of urea
and graphs were plotted. The results (Figure 6.3) showed no difference in the expression
of GFP from CFT073 (pCspH) and negative control in the absence or presence of urea.
Changing experimental conditions like reducing the temperature to 30oC, increasing the
gain of fluorescecne measurements and using black 96 well plate instead of clear plate
yielded no positive results. The cspH promoter region and GFPmut2 sequence in pCspH
plasmid were sequenced using Seq-primer and Seq-GFP primers respectively to make
sure that there were no mutations in these regions.

53

While troubleshooting, it was noticed that though expression of cspH is induced 8.4 fold
in CFT073 as a stress response to 0.6 M urea in microarray experiments (34), the actual
signal values for cspH gene expression in K medium without or with urea are very low
especially when compared to that of bax and ibpAB (Table 2). Thus the reason for not
being able to detect any fluorescence from CFT073 (pCspH) cultures compared to
negative control can be due to the weak activity of cspH promoter region.
To solve the issue, the copy number of pCspH plasmid was increased from ~5 to 50-70
copies per cell. This was done by replacing pSC101 origin of replication in pCspH
plasmid to ColE1 origin of replication (from pZE21-GFPaav plasmid). The constructed
plasmid was named pAL139-CspH. To construct pAL139 vector plasmid, which can be
used as a negative control, cspH promoter upstream GFPmut2 in pAL139-CspH plasmid
was replaced by a 24 bp DNA sequence as described in the methods section.
CFT073 and CFT073 ∆rpoS strains were transformed with pAL139-CspH or pAL139
vector plasmid and promoter activity assays were repeated using 0.3 M or 0.6 M urea in
K medium (Figure 6.4). Once again, a significant difference in the expression of GFP
was not seen in strains containing pAL139-CspH plasmid compared to negative control,
in the absence or presence of urea. Repeating the experiment in a black 96 well plate
reduced the background fluorescence but did not yield expected results (Figure 6.5).
It was noticed that the LB plates with streaks of CFT073 (pCspH) show fluorescence
slightly higher than CFT073 with pAL139 vector plasmid when observed under UV
transilluminator. Therefore streak plate experiments were performed to test the promoter
activity of cspH during urea stress. Before performing the experiments, pAL139-IbpAB
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plasmid was constructed as described in methods section to use as a positive control. A
single colony of CFT073 (pAL139-CspH), CFT073 ∆rpoS (pAL139-CspH), CFT073
(pAL139) - negative control and CFT073 (pAL139-IbpAB) - positive control were
streaked uniformly on each side of the K medium 1.5% agar plates according to the plate
layout (Figure 6.6). A single colony was used for each streak and the streaks were made
on 3 replicates of K medium agar plates, 3 replicates of K medium agar plates with 0.3 M
urea and 3 replicates of K medium agar plates with 0.6 M urea. The plates were incubated
at room temperature because urea degrades producing toxic products at higher
temperatures. The digital and fluorescence images were taken for the plates after 48 and
96 hours of incubation at room temperature. Results showed that there was an increased
fluorescence in cells with pAL139-CspH plasmid compared to negative control in K
medium plates with 0.3 M and 0.6 M urea. The increase in fluorescence was higher in 0.6
M urea compared to 0.3 M urea which was further higher than in K medium with no urea.
The expression of GFP was similar in CFT073 WT and CFT073 ∆rpoS strains containing
pAL139-CspH in the absence or presence of urea, indicating that the expression of cspH
might not be regulated by RpoS sigma factor during urea stress. However the results of
this experiment cannot be used to make definitive conclusions because the growth rate
differed significantly among the plates with different concentrations of urea. Though
replicate plates showed similar growth, it was noticed that CFT073 grew better on plates
with 0.3 M urea compared to plates with no urea. Interestingly, on 0.6 M urea plates,
CFT073 with pAL139-CspH plasmid showed reduced growth rate but the positive and
negative controls grew normally.
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Based on the results of streak plate experiments, it can be concluded that expression of
cspH might be induced during urea stress but not at high levels and this expression might
not be regulated by RpoS sigma factor. However these results need further confirmation.
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Figure 6.3: Expression of GFP from cspH promoter in pCspH plasmid during urea
stress in K medium. CFT073 strains containing pCspH plasmid and CFT073 with no
plasmid (negative control) were grown in microplate reader till exponential phase in K
medium and 0.3 M urea, 0.6 M urea or equal volumes of sterile water were added. The
absorbance (OD600) and fluorescence measurements were taken every 12 minutes before
and after the addition of urea and graphs were plotted. (A) RFU/ OD600, (B) RFU and (C)
OD600 measurements. Each data point represent mean + SEM of 3 independent
experiments from one culture.
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Figure 6.4: Promoter activity of cspH during urea stress in CFT073 wild type and
CFT073 ∆rpoS measured using pAL139-CspH plasmid in K medium. CFT073 and
CFT073 ∆rpoS strains with pAL139-CspH plasmid were grown in microplate reader till
exponential phase in K medium and 0.3 M urea, 0.6 M urea or equal volumes of sterile
water were added. CFT073 (pAL139 vector) was used as a negative control and treated
similar to other cultures. The absorbance (OD600) and fluorescence measurements were
taken every 12 minutes before and after the addition of urea and graphs were plotted. (A)
RFU/ OD600, (B) RFU and (C) OD600 measurements. Each data point represent mean +
SEM of 3 independent experiments from one culture.
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Figure 6.5: Promoter activity of cspH during urea stress in CFT073 wild type and
CFT073 ∆rpoS measured using pAL139-CspH plasmid in Costar black 96 well
plate. CFT073 and CFT073 ∆rpoS strains with pAL139-CspH plasmid were grown in
microplate reader using black 96 well plate till exponential phase in K medium and 0.3 M
urea, 0.6 M urea or equal volumes of sterile water were added. CFT073 (pAL139 vector)
was used as a negative control and treated similar to other cultures. The OD600 and
fluorescence measurements were taken every 12 minutes before and after the addition of
urea and graphs were plotted. (A) RFU/ OD600, (B) RFU and (C) OD600 measurements.
Each data point represent mean + SEM of 3 independent experiments from one culture.
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Figure 6.6: Growth and fluorescence images of cspH streak plate experiment plates
after 48 hours incubation at room temperature. K medium agar plates containing 0 M,
0.3 M or 0.6 M urea were streaked uniformly according to the plate layout with a fresh
colony of CFT073 ∆rpoS (pAL139-CspH), CFT073 (pAL139-CspH),

CFT073

(pUA139) - negative control and CFT073 (pAL130-IbpAB) - positive control,. The plates
were incubated at room temperature for 48 hours and digital images were taken to show
growth and florescence images were taken to show cspH promoter activity. There were 3
replicates for each condition but the images of only one replicate are shown.
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Figure 6.7: Growth and fluorescence images of cspH streak plate experiment plates
after 96 hours incubation at room temperature. K medium agar plates containing 0 M,
0.3 M or 0.6 M urea were streaked uniformly according to the plate layout with a fresh
colony of CFT073 ∆rpoS (pAL139-CspH), CFT073 (pAL139-CspH),

CFT073

(pUA139) - negative control and CFT073 (pAL130-IbpAB) - positive control,. The plates
were incubated at room temperature for 96 hours and digital images were taken to show
growth and florescence images were taken to show cspH promoter activity. There were 3
replicates for each condition but the images of only one replicate are shown.
.
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Deletion of cspH reduced the urea tolerance of BW25113 in M9 medium
Because expression of cspH was induced at low levels even during the presence of 0.6 M
urea, we were skeptical if cspH knockout of CFT073 would show any growth defect due
to urea stress. So the growth curve experiments were performed using only BW25113
wild type and its ∆cspH knockout (Keio strain). Knockout of cspH in BW25113 ∆cspH
(Keio strain) was confirmed though colony PCR as shown in Figure 6.8. Urea at 0.3 M,
0.6 M or 0.9 M concentrations or equal volumes of sterile water were added to
exponentially growing wild type and cspH null mutant of BW25113 in M9 medium. The
absorbance measurements were taken at 12 min interval before and after the addition of
urea and graphs were plotted. Results (Figure 6.9) showed that there is no difference in
the growth rate of BW25113 and BW25113 ∆cspH in M9 medium without or with 0.3 or
0.6 M urea. However at 0.9 M urea concentration, cspH null mutant showed slightly
reduced growth rate compared to the wild type BW25113. However further experiments
are needed to determine if this effect can be reverted by cspH expression plasmid.
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Figure 6.8: Confirmation of cspH knockout in BW25113 (Keio strain) by colony
PCR. Colony PCR was performed for BW25113 ∆cspH and BW25113 WT using 2
different primer pairs (K1, CspH-GFP-Fwd, CspH-RT-Fwd, CspH-RT-Rev) as shown by
the graphic images above the electrophoresis gel images. Lane M shows DNA ladder,
Lane 1 shows the colony PCR reaction results of BW25113 WT and Lane 2 shows the
colony PCR reaction results of BW25113 ∆cspH (Graphic images are not to scale).
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Figure 6.9: Effect of cspH knockout on the growth rate of BW25113 during urea
stress in M9 medium. Urea at 0.3 M, 0.6 M or 0.9 M concentrations or equal volumes of
sterile water were added to exponentially growing wild type and the cspH null mutant of
BW25113. The absorbance (OD600) measurements were taken every 12 minutes before
and after the addition of urea and graphs were plotted. Each data point represent mean +
SEM of 3 independent experiments from one culture.
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DISCUSSION AND CONCLUSIONS
Even though most UTIs can be treated effectively with antibiotics, a higher rate of its
recurrence and the rapid increase in the development of antibiotic-resistant UPEC strains
call for an alternative strategy to treat UTIs. Significant research is being conducted to
better understand the pathogenesis of urinary tract infections. However, the mechanism
behind how UPEC can tolerate high salt and urea levels in urine is still not clearly known
and is currently under investigation. Because UPEC strains are exposed to urine during
initial stages of infections, determining the genes or the mechanisms used to survive these
conditions would be valuable for the development of future UTI therapies. In this regard,
our lab conducted microarray experiments (34) to determine the differential expression of
genes in CFT073 during salt and urea stress. Based on the microarray results, 2 genes
(bax and cspH) and 1 operon (ibpA and ibpB) were chosen for the current study.
In the current project, the sequence conservation of the 4 genes (bax, ibpA, ibpB and
cspH) among 3 different UPEC strains CFT073, UTI89 and E. coli 536 and commensal
E. coli K-12 strain MG1655 was identified. This information will be useful to predict the
significance of these genes, as mutations or loss of important genes is a rare event during
the development of pathogenic strains. The results showed that all the 4 genes were well
conserved among these four strains.
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Because none of the known osmoregulatory systems were proven to be important for the
survival of E. coli in urine, it was speculated that E. coli uses an unknown mechanism to
survive in urine, which is yet to be discovered. On this note, bax is one of the interesting
genes to study, and encodes a hypothetical protein shown to be significantly induced
during salt stress in multiple studies. In the current project, using GFP promoter activity
assays, we demonstrated that expression of bax is induced significantly in CFT073 due to
the presence of 0.2 M and 0.3 M NaCl in K medium. This took us to our next step, which
is to determine if bax protects E. coli against salt stress. To accomplish this aim, bax
knockouts of BW25113 (K-12 strain) and CFT073 were used. In BW25113, lack of bax
caused reduced growth rate under salt stress compared to the wild type strain. In CFT073,
deletion

of

bax

did

not

affect

the

salt

tolerance

of

this

strain.

It is possible that an alternative mechanism exists in CFT073 which can compensate for
the lack of bax during salt stress. However further experiments are needed to confirm that
the reduced salt tolerance observed in BW25113 ∆bax is due to the lack of bax.
Two other genes that were upregulated under urea stress in CFT073 during microarray
experiments were ibpA and ibpB. Because urea is a protein denaturant, an induced
expression of several molecular chaperon genes including ibpAB operon was noticed in
CFT073 due to the presence of 0.6 M urea in K medium (34). In the present project this
was confirmed by constructing GFP transcriptional fusion plasmids and performing
promoter activity assays. It was already shown that ibpB is not required for CFT073 to
colonize murine urinary tract (55). Therefore CFT073 lacking both ibpA and ibpB, was
studied in the current project. Growth curve experiments were performed using ibpAB
null mutants of BW25113 and CFT073 in the absence or presence of 0.9 M urea in M9
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medium and K medium and it was noticed that lack of ibpAB had no effect on the urea
tolerance of these strains. Thus ibpAB is dispensable in CFT073 and BW25113 strains to
survive under urea stress in K medium and M9 medium.
Another gene that showed significantly induced expression in CFT073 due to presence of
0.6 M urea in K medium was CspH, which is speculated to be a DNA/RNA chaperone.
Since urea is a nucleic acid denaturant at higher concentrations (83), it was expected that
cspH might protect E. coli against denaturation effects of urea by acting as a DNA/RNA
chaperone. First, we wanted to prove that the expression of cspH was induced due to the
presence of urea by performing promoter activity assays using GFP transcriptional fusion
plasmid of cspH. Since cspH has a weak promoter, the expression of GFP from the GFP
transcriptional fusion plasmid of cspH was undetectable by the microplate reader. Hence,
streak plate experiments were performed, which showed that expression of cspH was
induced due to 0.3 M and 0.6 M urea stress in CFT073, but as CFT073 showed
inconsistent growth on plates with different concentrations of urea, these results need
further confirmation.
Considering the issues faced while performing promoter activity assays of cspH, we
decided to test if BW25113 ∆cspH (Keio strain) would show reduced urea tolerance
compared to wild type CFT073 before constructing CFT073 ∆cspH strain. The results
showed that in the presence of 0.9 M urea, BW25113 ∆cspH shows reduced growth rate
compared to the wild type BW25113.
RpoS is a stress responsive alternative sigma factor which was shown to influence the
expression of virulent genes in Salmonella and enterohaemorrhagic E. coli (22). The role
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of RpoS sigma factor in regulating the expression of bax, ibpAB and cspH genes under
high salt or urea levels was investigated in the current project and it was shown that RpoS
does not regulate the expression of these genes. However, regulation of cspH by RpoS
sigma factor needs further confirmation.
Future experiments that need to be performed to determine the importance of bax, ibpAB
and cspH genes in the uropathogenesis of E. coli are as follows:
(i)

Construction of CFT073 ∆cspH strain and cspH expression plasmid to test if
the reduced urea tolerance observed in BW25113 ∆cspH can be reproduced in
CFT073 and if this effect can be compensated by cspH expression plasmid.

(ii)

Confirm that the reduced salt tolerance of BW25113 ∆bax compared to the
wild type BW25113 was due to the lack of bax expression, by observing if
this effect can be reverted with bax expression plasmid.

(iii)

Perform in vitro growth curve experiments of bax, ibpAB and cspH knockouts
of CFT073 in urine

(iv)

Perform In vivo colonization experiments of bax, ibpAB and cspH knockout
strains of CFT073 in murine urinary tract

Though bax and ibpAB knockouts of CFT073 did not show reduced growth rate during
salt and urea stress respectively, in K medium and M9 medium compared to their
respective wild type strains, it would be worth testing if these knockouts strains show
reduced growth rate in urine or reduced colonization of murine urinary tract. These
experiments will help to fully assess their role in the uropathogenesis of E.coli.
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CFT073 is exposed to more severe stress in urine due to the presence of both salt as well
as urea at high levels, unlike in the current project in which CFT073 was exposed to
either high concentrations of salt or urea. Bax, IbpAB and CspH proteins were speculated
or proved to have other functions: for example Bax might have a potential role in
providing acid tolerance to enterohemorrhagic E. coli (41), proven importance of IbpAB
in the formation of E. coli biofilms (54), induced expression of ibpAB and cspH genes in
asymptomatic bacteriuria strains during biofilm growth in urine (52, 53). Therefore it
could be possible that bax, ibpAB and cspH null mutants of CFT073 might show reduced
growth rate in urine and show defective colonization of murine urinary tract by protecting
CFT073 against acidic pH in urine (bax) or playing a role in the formation of intracellular
bacterial community (ibpAB and cspH), in addition to their potential role in protecting
CFT073 against high levels of salt and urea in urine.
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